A61K 9/02
Suppositories
Official title: Suppositories; Bougies; Bases therefor; {Ovules}(apparatus for making A61J3/08; devices for introducing into the body A61M31/00)
A61K9/02 (Suppositories) appears on 636 US grants and 885 published applications in this corpus.
Search patents in A61K- Granted patents
- 636
- Published applications
- 885
- Assignees
- 464
- Inventors
- 1,623
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 5 | 0 |
| 1980 | 3 | 0 |
| 1981 | 9 | 0 |
| 1982 | 5 | 0 |
| 1983 | 8 | 0 |
| 1984 | 9 | 0 |
| 1985 | 4 | 0 |
| 1986 | 4 | 0 |
| 1987 | 4 | 0 |
| 1988 | 9 | 0 |
| 1989 | 9 | 0 |
| 1990 | 0 | 0 |
| 1991 | 5 | 0 |
| 1992 | 5 | 0 |
| 1993 | 8 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 11 | 0 |
| 2001 | 14 | 4 |
| 2002 | 15 | 14 |
| 2003 | 11 | 22 |
| 2004 | 8 | 26 |
| 2005 | 6 | 26 |
| 2006 | 13 | 27 |
| 2007 | 7 | 19 |
| 2008 | 7 | 31 |
| 2009 | 7 | 26 |
| 2010 | 13 | 32 |
| 2011 | 8 | 36 |
| 2012 | 18 | 26 |
| 2013 | 23 | 32 |
| 2014 | 30 | 44 |
| 2015 | 26 | 40 |
| 2016 | 25 | 33 |
| 2017 | 19 | 34 |
| 2018 | 20 | 39 |
| 2019 | 32 | 60 |
| 2020 | 37 | 72 |
| 2021 | 39 | 59 |
| 2022 | 38 | 50 |
| 2023 | 30 | 37 |
| 2024 | 23 | 37 |
| 2025 | 25 | 38 |
| 2026 | 10 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Progesterone formulation to trigger ovulation and provide luteal phase support15 Sep 2026US 12,734,179 B2Augusta University Research Institute, Inc.
- D-amphetamine compounds, compositions, and processes for making and using the same15 Sep 2026US 12,735,388 B2Zevra Therapeutics, Inc.
- Treatment of breast cancer with selective androgen receptor modulators and cyclin-dependent kinase 4/6 inhibitors21 Jul 2026US 12,685,719 B2University of Tennessee Research Foundation
- Substituted tetrazoles as ACSS2 inhibitors7 Jul 2026US 12,673,046 B2Merck Patent GmbH
- Multi-component intravaginal ring6 Aug 2026US 2026/0224475 A1
- Oxygen enema composition, enema device, and method for producing oxygen enema composition23 Jul 2026US 2026/0207658 A1MediScience Espoir Inc.
- Compounds, compositions, and methods9 Jul 2026US 2026/0193243 A1Tenvie Therapeutics, Inc.
- Methods of treating gastrointestinal diseases and disorders2 Jul 2026US 2026/0183233 A1Cristcot LLC
- New solid forms of (3r)-n-[2-cyano-4-fluoro-3-(3-methyl-4-oxo-quinazolin-6-yl)oxy-phenyl]-3-fluoro-pyrrolidine-1-sulfonamide18 Jun 2026US 2026/0167627 A1Hoffmann-La Roche Inc.
Most cited
By later US patents
- Tamper-resistant oral opioid agonist formulations343US 6,696,088 B2Euro-Celtique S. A. · 2004
- Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines288US 5,635,517 ACelgene Corporation · 1997
- Enteral pharmaceutical compositions266US 4,070,494 ABayer Aktiengesellschaft · 1978
- Treatment of female sexual dysfunction233US 6,294,550 B1Asivi, LLC · 2001
- Treatment of female sexual dysfunction212US 6,306,841 B1Asivi, LLC · 2001